Teplitsky Liane Rae purchased $100K of PLSE
Teplitsky Liane Rae (Chief Operating Officer) purchased 2,025 shares of PULSE BIOSCIENCES, INC. (PLSE) at an average of $49.37 ($48.80–$49.95) across 2 trades over 2026-08-31 to 2026-09-01.
How this was made
The 30-second read
Why it matters
The COO's purchase adds a modest positive data point but is unlikely to drive trading activity.
Market read
Small insider purchase; limited relevance for short-term traders.
What to watch
Potential upcoming corporate events or financing needs not disclosed.
Background
Form 4 filings disclose insider transactions; investors monitor them for signals.
Ticker impact
Chief Operating Officer purchased 2,025 shares for $99,971, increasing holdings to 4,095 shares.
Potential slight upside pressure, unlikely to move price materially.
The purchase is a primary Form 4 filing, providing new information, yet the dollar amount is small relative to typical market moves.
Market effects
Minimal effect on biotech sector; insider activity is routine.
None
None
Counterpoint
The purchase may be a routine compensation exercise, not a bullish signal.
Key entities
- OfficerTeplitsky Liane Rae
Chief Operating Officer of Pulse Biosciences, Inc.
